129 related articles for article (PubMed ID: 36595529)
1. SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma.
Choong OK; Jakobsson R; Bergdahl AG; Brunet S; Kärmander A; Waldenström J; Arvidsson Y; Altiparmak G; Nilsson JA; Karlsson J; Nyström K; Johansson ME
PLoS One; 2023; 18(1):e0279578. PubMed ID: 36595529
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
Tang Q; Wang Y; Ou L; Li J; Zheng K; Zhan H; Gu J; Zhou G; Xie S; Zhang J; Huang W; Wang S; Wang X
Int J Biol Sci; 2021; 17(8):1925-1939. PubMed ID: 34131396
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
5. Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells.
Kroll MK; Schloer S; Candan P; Korthals N; Wenzel C; Ihle H; Gilhaus K; Liedtke KR; Schöfbänker M; Surmann B; Schröter R; Neugebauer U; Mall G; Oswald S; Ludwig S; Rescher U; Vollenbröker B; Ciarimboli G
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979408
[TBL] [Abstract][Full Text] [Related]
6. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
[TBL] [Abstract][Full Text] [Related]
7. Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells.
Majidipur A; Morin-Dewaele M; Gaspar Lopes J; Berry F; Fouchet J; Bartier S; Dufros Duval A; Soyeux P; Huet E; Louis B; Coste A; Béquignon É; Saldana C; Le Corvoisier P; Destouches D; Pawlotsky JM; de la Taille A; Vacherot F; Bruscella P; Firlej V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834705
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and
Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
Roehrich H; Yuan C; Hou JH
Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
12. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.
Yang J; Li H; Hu S; Zhou Y
Aging (Albany NY); 2020 Apr; 12(8):6518-6535. PubMed ID: 32339157
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
14. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.
Chang CW; Parsi KM; Somasundaran M; Vanderleeden E; Liu P; Cruz J; Cousineau A; Finberg RW; Kurt-Jones EA
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891350
[TBL] [Abstract][Full Text] [Related]
15. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
16. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19.
Yang W; Li L; Zhang K; Ma K; Xie H; Gong Y; Zhou J; Gong K
Int J Biol Sci; 2021; 17(1):20-31. PubMed ID: 33390830
[TBL] [Abstract][Full Text] [Related]
17. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
Pique-Regi R; Romero R; Tarca AL; Luca F; Xu Y; Alazizi A; Leng Y; Hsu CD; Gomez-Lopez N
Elife; 2020 Jul; 9():. PubMed ID: 32662421
[TBL] [Abstract][Full Text] [Related]
18. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
19. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
20. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
